Pill with imprint D 02 is White, Capsule/Oblong and has been identified as Gabapentin 100 mg. It is supplied by Aurobindo Pharma.

Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs.

Risk cannot be ruled out during pregnancy. Gabapentin 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Gabapentin

Imprint

D 02

Strength

100 mg

Color

White

Size

16.00 mm

Shape

Capsule/Oblong

Availability

Prescription only

Drug Class

Gamma-aminobutyric acid analogs

Pregnancy Category

C – Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Aurobindo Pharma

Inactive Ingredients

corn starch, magnesium silicate, gelatin, titanium dioxide, sodium lauryl sulfate, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

Gabapentin 600mg

Gabapentin 600mg is a prescription medication typically used to treat conditions such as epilepsy, neuropathic pain, and certain types of seizures. If your healthcare provider has prescribed gabapentin 600mg for you, it’s important to follow their instructions carefully. Here are some general guidelines for taking gabapentin 600mg:

1. Dosage: Take gabapentin exactly as prescribed by your doctor. The typical starting dose for adults is 300mg taken orally twice a day, with the dose gradually increased as needed under your doctor’s supervision. Your doctor will determine the appropriate dose based on your medical condition and response to treatment.
2. Administration: Gabapentin tablets should be taken orally with plenty of water. Swallow the tablet whole; do not crush, chew, or break it. You can take gabapentin with or without food, but it’s important to take it consistently, either always with food or always on an empty stomach, to maintain consistent drug levels in your body.
3. Schedule: Take gabapentin at evenly spaced intervals to maintain a constant level of medication in your body. This helps ensure its effectiveness in managing your condition. If you are taking gabapentin more than once a day, try to take it at the same times each day to establish a routine.
4. Do not stop suddenly: Do not stop taking gabapentin abruptly without consulting your doctor, even if you feel better. Suddenly stopping gabapentin can cause withdrawal symptoms or worsen your condition. Your doctor may need to gradually taper your dose to safely discontinue the medication.
5. Interactions: Inform your doctor about all medications, supplements, and herbal products you are taking, as gabapentin can interact with certain drugs. This includes over-the-counter medications.
6. Pregnancy and breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of taking gabapentin with your doctor. Gabapentin may not be suitable during pregnancy or while breastfeeding.
7. If you are between the ages of 18 and 60, take no other medications, and have no other medical conditions, you are more likely to experience the following side effects with gabapentin:
   • Common Side Effects: Dizziness, drowsiness, tiredness, fever, and nystagmus (rapid, uncontrollable eye movements). Gabapentin-induced drowsiness can impair your ability to drive or operate machinery. Alcohol and other sedatives can enhance this effect.
   • Behavioral Changes in Children: When used to treat epilepsy in children aged three to twelve, gabapentin may cause behavioral problems, hostility, aggression, or thought disturbances.
   • Other Side Effects: Blurred vision, amblyopia (lazy eye), dry mouth, peripheral edema (fluid retention in feet and hands), tremor, sexual dysfunction, and gastrointestinal disturbances.
   • Titration: Gabapentin should be titrated up slowly to reduce the risk of side effects, although this may delay the onset of its effects.
   • Mental Health Risks: Similar to other anticonvulsants, gabapentin may increase the risk of depression and suicidal thoughts, especially in young adults under 24.
   • Discontinuation Syndrome: Abruptly stopping gabapentin can cause withdrawal symptoms such as anxiety, insomnia, nausea, pain, and sweating. It should be tapered off slowly under medical supervision.
   • Kidney Disease: The dosage needs to be reduced for individuals with kidney disease.
   • Hypersensitivity Reactions: Rarely, hypersensitivity reactions can occur, including fever, rash, swollen lymph nodes, swollen facial features, or throat swelling.
   • Drug Interactions: Gabapentin may interact with other medications, including antacids, hydrocodone, morphine, and other sedatives, potentially causing increased sedation or dizziness. It may also cause false-positive results on some urinary protein tests.
   • Misuse and Abuse: There have been reports of gabapentin misuse and abuse, especially in individuals with a history of drug abuse.
   • Administration: Gabapentin typically requires three times daily administration due to its short duration of effect. However, gabapentin enacarbil (brand name Horizant) is a long-acting prodrug that only requires once-daily dosing.
   • Seizure Disorders: Gabapentin is only effective for partial-onset seizures and not for other types of seizure disorders.
   • Interchangeability: Some branded and generic forms of gabapentin are not interchangeable.

Aurobindo Pharma

Aurobindo Pharma is a major Indian multinational pharmaceutical company that develops, manufactures, and distributes a wide range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). Here’s a detailed overview of the company:

Company Overview

1. Founding and History:
   • Founded: In 1986 by Mr. P. V. Ramprasad Reddy and Mr. K. Nityananda Reddy.
   • Headquarters: Hyderabad, Telangana, India.
   • Growth: Aurobindo Pharma has grown rapidly since its inception and is now one of the largest pharmaceutical companies in India and a significant player in the global market.
2. Operations and Facilities:
   • Manufacturing: Aurobindo has several manufacturing facilities across India, the United States, and other countries. These facilities are compliant with international regulatory standards such as the U.S. FDA, EMA, and WHO.
   • Research and Development: The company invests heavily in R&D with multiple state-of-the-art facilities in India and overseas, focusing on developing generic formulations, APIs, and biosimilars.
3. Product Portfolio:
   • Generics: Aurobindo offers a broad range of generic medications covering various therapeutic areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and anti-diabetics.
   • APIs: The company is a significant producer of active pharmaceutical ingredients used both in-house and by other pharmaceutical manufacturers.
   • Biosimilars and Specialty Products: Aurobindo is also involved in developing biosimilars and specialty pharmaceuticals, expanding its product offerings beyond traditional generics.
4. Global Presence:
   • Market Reach: Aurobindo Pharma has a significant presence in over 150 countries, including key markets like the United States, Europe, and emerging markets in Asia and Africa.
   • Subsidiaries: The company operates through numerous subsidiaries and joint ventures worldwide to strengthen its market position and distribution network.

Key Areas of Operation

1. Regulatory Compliance:
   • Quality Standards: Aurobindo adheres to stringent quality control measures and regulatory requirements to ensure the safety, efficacy, and quality of its products.
   • Approvals and Inspections: The company regularly undergoes inspections by regulatory authorities such as the FDA, EMA, and others to maintain compliance with international standards.
2. Research and Development:
   • Innovation: Aurobindo’s R&D efforts are focused on developing complex generics, novel drug delivery systems, and biosimilars.
   • Pipeline: The company has a robust pipeline of products in various stages of development, aimed at addressing unmet medical needs and expanding its market offerings.
3. Manufacturing Excellence:
   • Capacity: Aurobindo’s manufacturing facilities are equipped with advanced technology and have large production capacities, enabling the company to meet global demand efficiently.
   • Vertical Integration: The company’s vertical integration in API and formulation manufacturing provides cost advantages and ensures consistent supply chain management.
4. Strategic Acquisitions and Partnerships:
   • Expansion: Aurobindo has expanded its global footprint through strategic acquisitions and partnerships, enhancing its product portfolio and market access.
   • Notable Acquisitions: Examples include the acquisition of Sandoz’s U.S. dermatology and oral solids businesses, and Apotex’s businesses in select European countries.

Corporate Responsibility

1. Sustainability:
   • Environmental Practices: Aurobindo is committed to sustainable manufacturing practices, including reducing its carbon footprint, efficient waste management, and water conservation efforts.
   • Community Initiatives: The company engages in various CSR activities focused on healthcare, education, and community development.
2. Employee Welfare:
   • Workplace Safety: Aurobindo places a strong emphasis on workplace safety, health, and well-being of its employees.
   • Training and Development: The company invests in continuous training and professional development for its workforce.

Conclusion

Aurobindo Pharma is a prominent global pharmaceutical company known for its extensive range of generic medications and APIs. With a strong focus on research and development, regulatory compliance, and strategic growth, Aurobindo continues to expand its global presence and product portfolio. The company’s commitment to quality, innovation, and sustainability positions it as a key player in the pharmaceutical industry, contributing to making healthcare more affordable and accessible worldwide.